Overview

Bioavailability Study of Dronabinol Capsules 10 mg Under Fasting Conditions

Status:
Completed
Trial end date:
2006-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the rate and extent of absorption of Dronabinol 10 mg capsules verses Marinol.
Phase:
Phase 1
Details
Lead Sponsor:
Par Pharmaceutical, Inc.
Collaborator:
BASi Clinical Research Unit
Treatments:
Dronabinol